casein hydrolysate

Health claim: casein hydrolysate – a reduction of post-prandial blood glucose responses

Following an application from Food for Health Ireland (FHI), submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of Ireland, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to FHI LFC24, a bovine milk-derived casein hydrolysate, and a reduction of post-prandial blood glucose responses.

The food, FHI LFC24, which is the subject of the health claim, is sufficiently characterised.

The claimed effect proposed by the applicant is that FHI LFC24, when co-ingested with carbohydrates, reduces post-prandial blood glucose responses.

The target population proposed by the applicant is the healthy adult population. In view of the proposed mechanism by which the food would exert the claimed effect, i.e. ‘by increased post-prandial insulin secretion’, the applicant was requested to provide evidence that a reduction of post-prandial blood glucose responses achieved by an increase in insulin secretion is a beneficial physiological effect for the target population, i.e. the healthy adult population. The evidence provided by the applicant did not establish that a reduction in post-prandial glycemic responses achieved by an increase in insulin secretion is a beneficial physiological effect for the target population. The Panel considers that a cause and effect relationship has not been established between the consumption of the food, FHI LFC24, and a beneficial physiological effect for the target population.

Continue reading below

DON’T MISS A THING!! Top stories about healthy aging direct to your inbox.

Sign up for our FREE newsletter about how nutrition affects healthy aging. Receive it every Monday conveniently in your mailbox. Sign up now!

* marked fields are required.

We dislike spam as much as you do! Unsubscribe is easy! Guaranteed!

Confirm your signup through the confirmation email. Please check also your spam folder.

Continue reading

The evidence provided by the applicant did not establish that a reduction in postprandial glycemic responses achieved by an increase in insulin secretion is a beneficial physiological effect for the target population. The Panel considers that a cause and effect relationship has not been established between the consumption of the food, FHI LFC24,, a bovine milk-derived casein hydrolysate, and a beneficial physiological effect for the target population.

Click here for the full article in the EFSA journal


Was This Post Helpful:

0 votes, 0 avg. rating

Share: